The growing incidence of lifestyle diseases such as cardiovascular disease (CVD)‚ cancer‚ diabetes and respiratory disease‚ in addition to infectious and parasitic illness‚ will present the pharmaceutical industry in Africa with a business opportunity of $40.8bn in 2019‚ according to research by Frost & Sullivan. And the pharmaceuticals market in Africa is expected to represent a business opportunity of $45bn by 2020‚ it added. "An increase in health spending will encourage local manufacture of drugs‚" said Transformational Health research analyst Saravanan Thangaraj. "We expect this increase in local formulation and filling to be protected by regulatory and tariff barriers‚ so international players will be looking for local contract manufacturers and other strategic partnerships." A report‚ titled African Pharmaceuticals Market‚ Forecast to 2020‚ part of Frost & Sullivan’s Life Sciences Growth Partnership Service programme‚ aims to provide insights for big pharmaceutical companies ...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now